Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Stakeholder-informed Health Economic Model to Assess the Costs and Benefits of RSV Monoclonal Antibody Implementation for Infants in Botswana

NCT07756528 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT07756528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07756528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Stakeholder-informed Health Economic Model to Assess the Costs and Benefits of RSV Monoclonal Antibody Implementation for Infants in Botswana
Lead sponsor
University of California, San Diego
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2026
Completion date
December 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rsv